Qingdao Baheal Pharmaceutical Co. Ltd. (301015)
Market Closed
16 Oct, 06:57 AM
XSHE XSHE Primary ¥
22. 60
-1.31
-5.4789%
¥
10.39B Market Cap
26.83 P/E Ratio
3.05% Div Yield
33.01M Volume
0 Eps
¥ 23.91
Previous Close Want to track 301015 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Qingdao Baheal Pharmaceutical Co. Ltd. (301015) Statistics
Valuation metrics
Market Cap 10.39B
Enterprise value 15.69B
Trailing P/E (ttm) 27.11
Forward P/E -
PEG ratio 2.1
Price/Sales (ttm) 1.86
Price/Book (mrq) 5.69
Enterprise Value/Revenue 2.14
Enterprise Value/EBITDA 15.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 8.36M
Average volume (90 days) 8.79M
Price summary
52-Week low 18.4
52-Week high 28.77
Beta -
50-Day moving average 24.66
200-Day moving average 23.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.57
Trailing annual dividend yield 0.022%
5-Year annual dividend yield -
Payout ratio 0.68
Dividend Date 1 Jun 2026
Ex-Dividend Date 1 Jun 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.92
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.13
Total debt (mrq) -
Total Debt/Equity (mrq) 1.6
Current ratio (mrq) 1.43%
Book value per share (mrq) 5.19
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
